Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.2 USD
100.78 M USD
838.00 M USD
170.31 M
About HUTCHMED (CHINA) LIMITED
Sector
CEO
Wei Guo Su
Headquarters
Hong Kong
Website
Founded
2000
FIGI
BBG00JVRNR90
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.
HCM Learning experiencePlaying Trading Simulator:
Big time rookie mistake.
Bought 350 shares at $41.71 on 3JAN18. Price was falling.
Same day bought 500 shares at $39.93 in order to dilute my buying price.
I began studying the chart and saw my mistake.
On 5JAN18 I sold my shares using a trailing stop of 10 cents.
It exe
Tracking HCMI've been a long term holder of HCM since 2009. They are also listed on the FTSE AIM 100 LSE:HCM.
They have outperformed the NASDAQ BIOTECHNOLOGY INDEX INDEX:NBI
Now would be a good place to exit.
I will continue to hold for now, i am not trading this. It's included in my long term portfolio.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.